Most first-time founders spend weeks agonizing over the wrong lines in a VC term sheet. Here's what actually matters and what you can safely ignore.
A term sheet lands in your inbox and suddenly you're expected to become a securities lawyer overnight. Understanding what is a term sheet is genuinely simple: it's a non-binding document that outlines the key economic and governance terms of a proposed investment before the legal agreements are drafted. But "non-binding" is doing a lot of work in that sentence. The economics baked into a term sheet, particularly the liquidation preference, follow your company for its entire life. Get them wrong at Series A and you can build a $50 million outcome where the founders walk away with almost nothing. That happens more than VCs tend to mention.
The document itself typically runs five to ten pages and covers two broad categories: economic terms and control terms. Economic terms determine who gets paid what, and when. Control terms determine who gets to make decisions. Founders often fixate on the valuation, which is visible and feels like the score. The real game is usually elsewhere.
Liquidation preference is where most founders get quietly cleaned out. It sounds technical, but the concept is straightforward. If an investor puts in $5 million with a 1x non-participating liquidation preference and the company sells for $20 million, the investor takes their $5 million back first, then converts to equity and participates in the remaining $15 million proportionally. That's standard and reasonably fair.
The version that should make you nervous is participating preferred, sometimes called "double-dip." Under that structure, the investor takes their money back first and then shares in the remaining proceeds as if they also held common stock. Y Combinator's standard Series A term sheet explicitly prohibits participating preferred precisely because of how badly it can compress founder returns. At a $15 million exit with 25% investor ownership and $5 million in participating preferred, the founders might expect to pocket $7.5 million. The actual number could be closer to $5.6 million. That difference is enough to change what you do next.
Multiple liquidation preferences, where an investor gets 2x or 3x their money back before anyone else sees a dollar, nearly disappeared after the dot-com crash but crept back during tighter capital markets. If a term sheet you're looking at has anything above 1x, push back. Most reasonable investors will accept 1x non-participating if the company and deal are worth doing.
Anti-Dilution, Pro-Rata, and Board Control
Anti-dilution provisions protect investors if you raise a future round at a lower valuation than the current one, a down round. There are two common flavors. Full ratchet adjusts the investor's conversion price down to the new, lower price. It's brutal and almost never seen in standard early-stage deals anymore. Weighted average, the version you'll encounter in nearly every modern term sheet, does the same thing but in a more measured way, averaging the old and new price weighted by the number of shares. Broad-based weighted average is more founder-friendly than narrow-based. If a term sheet simply says "weighted average" without specifying, ask which version. It matters in a down round.
Pro-rata rights give existing investors the right to participate in future funding rounds to maintain their ownership percentage. For a small angel check, these rights are mostly harmless. For a larger institutional investor with a big ownership stake, pro-rata rights can complicate future rounds by limiting how much room new investors have to write the checks they want. Some founders negotiate to cap pro-rata rights at a defined percentage of a future round rather than accepting an open-ended commitment. That's a reasonable ask and most investors will agree to it.
Board composition deserves more attention than most first-time founders give it. A typical early-stage deal might result in a five-person board: two founders, one investor, and two independent directors. The fight is usually over who picks the independents, because they're the swing votes. If the term sheet gives the lead investor the unilateral right to select independent board members, you've handed control of the board to someone else while technically holding more seats. Push for a structure where both common and preferred shareholders have to approve independent board appointments. That mutual consent is worth negotiating for.
What VCs Use as Distractions
Drag-along rights allow a majority of shareholders to force the rest to approve a sale. Founders often get spooked by them, but they're almost always benign at the early stage. If the majority of your common stockholders and the majority of preferred stockholders both have to agree to trigger drag-along, it's basically a non-issue. Where it becomes dangerous is when a term sheet lets preferred stockholders alone trigger the drag. Read that sentence carefully, then rewrite it if you need to.
Dividends are another clause that looks scary in the abstract and matters almost never in practice. Most early-stage VCs include a cumulative dividend clause, meaning unpaid dividends accrue on paper. Unless the dividend rate is unusually high, say above 10%, these clauses rarely affect an actual outcome because they only get paid in a liquidation event where the preference stack is already dominating the math.
Redemption rights, which theoretically allow investors to force the company to buy back their shares, are common on paper and exercised almost never. A founder losing sleep over redemption rights is probably not reading the liquidation preference clause carefully enough.
Term Sheet vs SAFE: What Applies and When
If you're raising a pre-seed round, you may not see a term sheet at all. Many early-stage investors now use a SAFE, a Simple Agreement for Future Equity, developed by Y Combinator in 2013. A SAFE isn't equity and it isn't debt. It's a promise to convert into equity at a future priced round, usually with a valuation cap and sometimes a discount. SAFEs are faster and cheaper to close than priced rounds because they skip the full term sheet negotiation entirely.
The practical difference matters in dollars. A term sheet kicks off a full priced round with legal costs often running $15,000 to $30,000 for both sides. A SAFE can be closed in days with far less legal overhead. The tradeoff is that with a SAFE you're deferring the hard negotiation around valuation and dilution until your Series A, when the investor converts. If you stack multiple SAFEs at different caps, the conversion math at Series A can produce more dilution than founders expect. Model it out before you sign.
Post-money SAFEs, which Y Combinator switched to in 2018, calculate dilution from the post-money value of the company including the SAFE itself. That made the dilution more predictable for investors and more dilutive for founders compared to the older pre-money version. If someone hands you a SAFE and says "don't worry, it's standard YC," check the vintage. The 2018 version and the earlier version behave differently at conversion, and the difference compounds as you raise more capital.
A term sheet is ultimately a negotiation document, and the power to negotiate depends almost entirely on how much competition exists for your round. Two interested VCs produces a better term sheet than one. That's not a philosophical point, it's just how it works. Build competition where you can, close when you have leverage, and spend your negotiating energy on the liquidation preference, the anti-dilution mechanics, and board composition. The rest is mostly paperwork.
Also read: What is token vesting and how it differs from startup equity • How to Build an AI Agent for Your Business Without Writing Code • What Is a SAFE Note and How It Actually Works for Startup Fundraising
